Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
OverviewMechanism of ActionHow To UseUsesBenfitsIndicationsMethod of AdministrationDosage StrengthsDosage FormsDietary RestrictionsContraindicationsAdverse ReactionsSide EffectsOverdosage Clinical Pharmacology Authored by Reviewed by References
Fenoterol

Fenoterol

Indications, Uses, Dosage, Drugs Interactions, Side effects
Fenoterol
Medicine Type :
Allopathy
Prescription Type:
Prescription Required
Approval :
DCGI (Drugs Controller General of India)
Schedule
Schedule H
Pharmacological Class:
Beta 2 Adrenergic Receptor Agonist,
Therapy Class:
Bronchodilator,

Fenoterol belongs to the pharmacological class of Beta 2-adrenergic agonists. Fenoterol appears to have bronchodilating properties.

Fenoterol had been approved for relieving symptoms as well as for the treatment and maintenance of episodes of asthma and bronchospasm.

Fenoterol is available in Germany, India, Japan.

Fenoterol belongs to the pharmacological class of Beta 2-adrenergic agonists. Fenoterol appears to have bronchodilating properties.

Fenoterol had been approved for relieving symptoms as well as for the treatment and maintenance of episodes of asthma and bronchospasm.

Fenoterol is an adrenergic beta-2 agonist. Asthma results from a narrowing of the bronchial tubes. This narrowing is caused by muscle spasm and inflammation within the bronchial tubes. Agonism of the beta-2 adrenergic receptors by Fenoterol leads to a relaxation of the smooth muscles surrounding these airway tubes which then increases the diameter and ease of air flow through the tubes.

The common side effects associated with the use of Fenoterol is headache , dizziness, nervousness,shakiness, and cough.

Fenoterol is available in the form of the Inhalation solution,Metered dose inhaler ,Oral solutions and Oral tablets.

Fenoterol is available in the form of the Inhalation solution,Metered dose inhaler ,Oral solutions and Oral tablets.

Fenoterol had been used in the treatment of the following conditions

  • Asthma
  • Bronchospasm

Fenoterol can help to relieve symptoms and also for the treatment and maintenance of asthma and bronchospasm.

Fenoterol was used following clinical indications/conditions:

  • Asthma
  • Bronchospasm

Oral Inhalation:

Metered Dose Inhalers:

1. Remove cap. Some caps must be squeezed at the sides to release it.

2. Check the dose counter of the device .

3. Hold the inhaler upright and shake well before use.

4. Now breathe out gently away from the inhaler before inhaling.

5. Put mouthpiece between teeth and close lips tightly

6. Slowly breathing through mouth and at the same time press down firmly on canister slowly simultaneously

7. Take a slow and deep breath

8. Hold breath for about 5 or 10 seconds or as long as comfortable

9. While holding breath, remove the inhaler from mouth

10. Breathe out gently away from inhaler

11. Repeat all steps starting from step 3,if more than one dose is needed,

12. Replace cap

Oral Tablet:

To be swallowed as a whole with water.

Adults:

Asthma or bronchospasm, acute:

Oral inhalation:

Metered-dose inhaler: Mild to moderate symptoms: 1 inhalation initially; may repeat in 5 minutes as needed; maximum dose: 8 inhalations/day. For severe exacerbation of asthma: 4 inhalations every 10 minutes or 8 inhalations every 20 minutes for up to 4 hours, then every 1 to 4 hours as needed.

Solution for nebulization: Mild to moderate symptoms: 0.5 to 1.25 mg (2 to 5 drops) every 4 hours as needed; maximum: 2 mg (8 drops)/day. For severe exacerbation of asthma: 2.5 to 5 mg (10 to 20 drops) inhaled via nebulization every 20 minutes for 3 doses, then 2.5 to 10 mg (10 to 40 drops) every 1 to 4 hours as needed.

Oral:

Solution: Oral: 2.5 to 5 mg 3 times daily

Tablets: Oral: 2.5 mg 3 times daily

Exercised-induced bronchospasm: Oral inhalation:

Metered-dose inhaler: 1 or 2 inhalations prior to exercise; maximum dose: 8 inhalations/day

Solution for nebulization: 0.5 mg (2 drops) inhaled prior to exercise

Inhalation solution,Metered dose inhaler , Oral solutions and Oral tablets.

Smoking cessation and maintaining health is a must.

Caffeine should be avoided or limited to use as it might lead to the risk of nausea, palpitations, nervousness, rapid heartbeat, etc.

Alcohol intake should be avoided in the patients, especially with an underlying liver disorder or liver dysfunction.

Diet containing food with high sugar content and also carbohydrates should be restricted.This includes jams, candies,pies, cakes, honey,cookies,chips and bread. It is also advised to reduce as well as limit the intake of cholesterol and saturated fat and instead choose poultry, lean meat or fish.

The dietary restrictions should be individualized as per the patient's requirements.

Fenoterol may be contraindicated under the following conditions:

  • Hypersensitivity to the ingredients of the medication.

The adverse reactions related to Fenoterol can be categorized as

  • Dizziness
  • Headache
  • Shakiness
  • Nervousness
  • Cough

The common side effects of Fenoterol include the following:

  • Dizziness
  • Headache
  • Shakiness
  • Nervousness
  • Cough

As Fenoterol is absorbed only to a very limited extent, no action other than medical observation should be necessary alone or with symptomatic treatment if any symptoms appear.

Pharmacodynamics

Fenoterol, an adrenergic bronchodilator, widens constricted airways in the lungs by relaxing the smooth muscles that surround the bronchial passages.

  1. https://wwhttps://drugcentral.org/drugcard/1155
  2. w.medicinenet.com/fenoterol_inhalation_solution-oral/article.htm
  3. https://pharmaoffer.com/api-excipient-supplier/fenoterol/fda
  4. https://go.drugbank.com/drugs/DB01288
undefined
Sonali R Muralidhar
I am Sonali R Muralidhar currently residing at Madurai.I have completed my Master’s in Pharmacy with my core subject as Pharmaceutics. I am interested in Pharmaceutical research , medical content writing, Biopharmaceutics , regulatory affairs , novel drug delivery, targeted drug delivery.
undefined
Dr JUHI SINGLA
Dr JUHI SINGLA has completed her MBBS from Era’s Lucknow Medical college and done MD pharmacology from SGT UNIVERSITY Gurgaon. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
Published on: 25 Jan 2023 6:10 PM GMT
© 2022 All Rights Reserved.
Powered By: Hocalwire
X
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok